Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2012-06-07 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FRANCONVILLE (95130), Val-d'Oise
PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX : revenue, balance sheet and financial ratios
PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FRANCONVILLE (95130),
this company of category PME
shows in 2023 a revenue of 2.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX (SIREN 751991795)
Indicator
2023
2022
Revenue
2 026 761 €
2 073 867 €
Net income
132 339 €
168 294 €
EBITDA
175 468 €
237 056 €
Net margin
6.5%
8.1%
Revenue and income statement
In 2023, PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX achieves revenue of 2.0 M€. Slight decline of -2% vs 2022. After deducting consumption (1.5 M€), gross margin stands at 544 k€, i.e. a rate of 27%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 175 k€, representing 8.7% of revenue. Warning negative scissor effect: despite revenue change (-2%), EBITDA varies by -26%, reducing margin by 2.8 pts. This reflects costs rising faster than revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 132 k€, i.e. 6.5% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2023)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
2 026 761 €
Gross margin (2023)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
543 892 €
EBITDA (2023)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
175 468 €
EBIT (2023)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
180 731 €
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
132 339 €
EBITDA margin (2023)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
8.7%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 91%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 6.6 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 6.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
90.967%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
49.572%
Cash flow / Revenue (2023)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
6.643%
Repayment capacity (2023)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
6.56
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2022
2023
Debt ratio
130.433
90.967
Financial autonomy
41.071
49.572
Repayment capacity
6.449
6.56
Cash flow / Revenue
8.18%
6.643%
Sector positioning
Debt ratio
90.972023
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.22
Average-7 pts over 2 years
In 2023, the debt ratio of PHARMACIE DU CENTRE COMME... (90.97) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
49.57%2023
2022
2023
Q1: 28.71%
Med: 48.51%
Q3: 68.18%
Good+9 pts over 2 years
In 2023, the financial autonomy of PHARMACIE DU CENTRE COMME... (49.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
6.56 years2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE DU CENTRE COMME... (6.56) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 476.33. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 8.1x. Operating income very largely covers interest expenses: high safety margin.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
476.326
Interest coverage (2023)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
8.142
Liquidity indicators evolution PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2022
2023
Liquidity ratio
565.94
476.326
Interest coverage
7.299
8.142
Sector positioning
Liquidity ratio
476.332023
2022
2023
Q1: 135.26
Med: 189.75
Q3: 270.27
Excellent
In 2023, the liquidity ratio of PHARMACIE DU CENTRE COMME... (476.33) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
8.14x2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent
In 2023, the interest coverage of PHARMACIE DU CENTRE COMME... (8.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 4 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 18 days. Favorable situation: supplier credit is longer than customer credit by 14 days. Inventory turnover is 19 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 23 days of revenue, i.e. 131 k€ to permanently finance.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
131 334 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
4 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
18 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
19 j
WCR in days of revenue (2023)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
23 j
WCR and payment terms evolution PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2022
2023
Operating WCR
135 299 €
131 334 €
Inventory turnover (days)
20
19
Customer payment term (days)
6
4
Supplier payment term (days)
16
18
Positioning of PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX is estimated at
1 604 668 €
(range 1 015 270€ - 2 070 846€).
With an EBITDA of 175 468€, the sector multiple of 10.0x is applied.
The price/revenue ratio is 0.69x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1015k€1604k€2070k€
1 604 668 €Range: 1 015 270€ - 2 070 846€
NAF 5 année 2023
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
175 468 €×10.0x
Estimation1 746 944 €
1 047 995€ - 2 227 759€
Revenue Multiple30%
2 026 761 €×0.69x
Estimation1 396 302 €
1 004 481€ - 1 726 451€
Net Income Multiple20%
132 339 €×11.8x
Estimation1 561 531 €
949 642€ - 2 195 162€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX with other companies in the same sector:
Frequently asked questions about PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX
What is the revenue of PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX ?
The revenue of PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX in 2023 is 2.0 M€.
Is PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX profitable?
Yes, PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX generated a net profit of 132 k€ in 2023.
Where is the headquarters of PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX ?
The headquarters of PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX is located in FRANCONVILLE (95130), in the department Val-d'Oise.
Where to find the tax return of PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX ?
The tax return of PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX operate?
PHARMACIE DU CENTRE COMMERCIAL CADET DE VAUX operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart